The Parallel EMA/EUnetHTA 21 Joint Scientific Consultations (JSCs) under the EUnetHTA 21 service contract will have to be completed by September 2023 and all available slots have already been allocated.
To bridge the interim period between the closure of EUnetHTA 21 and the full application of the HTA Regulation in January 2025, EMA and national HTAb will offer Health technology developers (HTDs) the opportunity for parallel scientific advice:
HTDs will be able to apply for Parallel EMA/HTA body (HTAb) Scientific Advice from September 2023, when EUnetHTA 21 ceases to operate, until January 2025 when Regulation (EU) 2021/2282 on health technology assessment will become fully applicable.
More information can be found here.
